Delivery Order 36C24922D0027-36C24923N0501

Award Date 9/23/23
Potential Completion Date 9/22/24
Potential Value $393K
Contracting Federal Agency
Veterans Integrated Service Network 9
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Murfreesboro, TN 37129, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $392,628.24, was issued by the Veterans Integrated Service Network 9 (VISN 9) of the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization that specializes in providing advanced medical testing products and services to support organ transplant programs. The contract covers the provision of Caredx's AlloMap and AlloSure genetic blood testing services for transplant patients. Caredx has a strong history of securing VA contracts for...
This is a $193,171.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract is for laboratory reference testing services, specifically Caredx's specialized diagnostic solutions for organ transplant patients, including its AlloMap and AlloSure genetic and molecular testing products. The contract has an ultimate completion date of January 14,...
This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
The Department of Veterans Affairs has awarded a firm-fixed-price delivery order to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., a leading provider of genomics-based solutions for transplant patients. The contract, valued at $59,931.70, is for the provision of the AlloMap molecular testing service to support post-transplant surveillance for veterans receiving specialty transplant care within the VA's Veterans Integrated Service Network 17. This delivery order is issued against a...
This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
This is a $245,479.74 firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract is for the provision of testing kits for post-transplant patients and does not have a set-aside designation. Caredx, headquartered in Brisbane, California, will provide specialized...
The Department of Veterans Affairs (VA) awarded a $247,578.50 firm fixed-price purchase order contract to Caredx, Inc., a for-profit healthcare organization, for the provision of AlloSure kidney donor-derived cell-free DNA testing kits and services. The contract has an ultimate completion date of October 18, 2027 and was issued through the VA's Veterans Integrated Service Network (VISN) 6. The original solicitation was an unrestricted request for AlloSure kidney testing kits to support the...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Caredx Lab Solutions Inc., a for-profit manufacturer of genomics-based solutions for transplant patients. The $59,931.70 contract provides CAREDX ALLOMAP molecular testing services to support post-transplant surveillance and patient management for heart transplant recipients within the VA network. The contract is an indefinite delivery vehicle with a...
This is a federal contract award to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $4,807,230.45, is for laboratory tests for post-transplant organ rejection and was awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of March 31, 2026....
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Caredx, Inc., a for-profit company that provides kidney care solutions. The $139,400.00 firm fixed price purchase order is for Caredx to supply specialized medical testing products and services related to organ transplant patients, including AlloMap gene testing, AlloSure kidney testing, and XYNQAPI renal transplant software. This contract is not associated with any set-aside...
  • 36C24922D0027
    Indefinite Delivery Contract
  • 36C24922D0027-36C24923N0501
    Delivery Order

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $392,628.24 delivery order contract to Caredx, Inc., doing business as Caredx, located in Murfreesboro, Tennessee. The firm fixed price contract is for the period of September 23, 2023 through September 22, 2024 and is for Genetic Blood Testing for Transplant Patients (AlloMap and AlloSure). Caredx will provide their AlloMap and AlloSure products, which are used to help assess the risk of organ rejection in transplant patients, to support the VA's transplant program under this contract.

Generated 11/28/23, 5:35 PM